Japanese tech leader Toshiba has pioneered a system that identifies cancer from a single drop of blood. Boasting exceptional precision, this technology promises earlier detection and better outcomes.
Cancer ranks as the world's second leading cause of death, per the World Health Organization (WHO). In 2018 alone, it claimed 9.6 million lives and saw around 18 million new diagnoses. Too often, symptoms emerge only at advanced stages, leading to prolonged, grueling treatments.
As reported in The Japan Times on November 25, 2019, Toshiba's breakthrough analyzes one drop of blood to detect cancer with 99% accuracy. Researcher Koji Hashimoto highlights its affordability at just 20,000 yen (about €166).
The system quantifies microRNA concentrations in the blood—tiny molecules more prevalent in cancer cells. It screens for 13 cancer types, such as pancreatic, ovarian, liver, bladder, and prostate, according to Hashimoto. Though not yet widespread, its low cost positions it for easy inclusion in standard health screenings, enabling early intervention and avoiding harsh therapies.
Early detection research is advancing rapidly. Recently, IBM launched AI-powered tools to scour data, design drugs, and forecast cancer progression.
Source
Related Articles:
